Connect with Us
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2024 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.
Dr. Robin Winter-Sperry started working in the industry in the area of Dermatology. She has had a long and distinguished career including Sanofi/Genzyme Global Medical Affairs, Strategy & Tactics in the area of Multiple Sclerosis and President and CEO of Scientific Advantage, LLC. She created Novartis’ Medical Science Liaison (MSL) department of Scientific Operations and Sanofi-Synthelabo’s Medical Therapeutic Liaison division.
She has been involved in over 28 product launches. She has pioneered the recognition of MSLs as a specialty in the biopharmaceutical and device industry and is responsible for creating and developing many of the industry’s leading Medical Affairs and Medical Liaison teams.
Tim Mikhelashvili is the Founder and CEO of Amedea Pharma, Inc. and also a Director, Medical Science Liaison at UroGen Pharma. He is a Doctor of Pharmacy with a Post-Doctoral Fellowship in Scientific Publications and Medical Education from Rutgers with 16 years of experience in headquarters and field-based Medical Science Liaison and Trainer roles spanning both large, established companies such as Sanofi and AstraZeneca early in his career, as well as rare disease start-up companies such as Salix, Baxalta, Synergy, and UroGen. Passionate about company culture and performance metrics, he has driven company-wide leadership initiatives. He is certified by MIT Sloan in “Leading Organizational Change”, and is currently focused on transforming the Medical Affairs function to take the lead in helping the pharmaceutical industry grow its reputation and trust from patients and providers.
Amedea Pharma, Inc. is his organizational and performance management consulting company inspired by innovative analytic techniques “to transform numbers into stories”, meanings, and future behaviors. He advises artificial intelligence start-ups and professional societies, writes articles, creates and delivers courses and webinars about Field Medical Insights, Metrics, and Virtual Engagement. Finally, Tim is the host of his inspirational @Alloutcoach Podcast and YouTube Channel dedicated to breaking down barriers between people and extending the boundaries of human responsibilities and abilities, where his slogan is “stretch yourself, lift others”, and his personal goal is to create more leaders.
Dr. Kirk Shepard has more than 25 years of experience in the pharmaceutical industry. He is a board-certified medical oncologist and hematologist physician. He is currently Chief Medical Officer, Senior Vice President, Head of Global Medical Affairs OBG at Eisai Pharmaceutical Company.
Dr. Shepard’s experience in multiple therapeutic areas includes operational and strategic product development from Phases I through IV and the diverse disciplines of medical affairs and product commercialization, such as leading compliance and SOP/policy efforts, health economics & outcomes research & patient access, data generation, field-based medical teams (MSLs), PV/safety, medical communication & publications, patient advocacy, and public relations. In 2015, he was selected as one of the 100 Most Inspiring People in the Pharmaceutical Industry (PharmaVOICE).
Before his pharmaceutical career, Dr. Shepard served as a staff physician in the Department of Hematology and Medical Oncology at the Cleveland Clinic Foundation, where he supervised numerous studies in oncology and symptom control. He has more than 50 medical publications in journals and books. Dr. Shepard earned his bachelor’s degree from Cornell University in Ithaca, NY, and his medical degree from the University of Cincinnati Medical School in Cincinnati, OH. He completed both his internship and residency in internal medicine at Case Western Reserve University in Cleveland, OH, and fellowships in hematology and oncology at the University of Chicago Hospitals and Clinics in Chicago, IL.
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2024 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.